How I treat posttransplant lymphoproliferative disorder

被引：14

作者：

Amengual, Jennifer E. ^{[1
,2
]}

Pro, Barbara ^{[1
]}

机构：

[1] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Div Hematol & Oncol, New York, NY USA

[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Div Hematol & Oncol, 161 Ft Washington Ave,Garden Level, New York, NY 10032 USA

来源：

BLOOD | 2023年 / 142卷 / 17期

关键词：

SOLID-ORGAN TRANSPLANT; T-CELL THERAPY; BRENTUXIMAB VEDOTIN SGN-35; ADOPTIVE IMMUNOTHERAPY; AMERICAN SOCIETY; 2ND-LINE THERAPY; DONOR LEUKOCYTES; LYMPHOMA; DISEASE; SURVIVAL;

D O I：

10.1182/blood.2023020075

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Posttransplant lymphoproliferative disorder (PTLD) is an important and potentially life-threatening complication of solid organ transplant and hematopoietic stem cell transplant (HSCT). Given the heterogeneity of PTLD and the risk of infectious complications in patients with immunosuppression, the treatment of this disease remains challenging. Monomorphic PTLD and lymphoma of B-cell origin account for the majority of cases. Treatment strategies for PTLD consist of response-adapted, risk-stratified methods using immunosuppression reduction, immunotherapy, and/or chemotherapy. With this approach, similar to 25% of the patients do not need chemotherapy. Outcomes for patients with high risk or those who do not respond to frontline therapies remain dismal, and novel treatments are needed in this setting. PTLD is associated with Epstein-Barr virus (EBV) infection in 60% to 80% of cases, making EBV-directed therapy an attractive treatment modality. Recently, the introduction of adoptive immunotherapies has become a promising option for refractory cases; hopefully, these treatment strategies can be used as earlier lines of therapy in the future.

引用

页码：1426 / 1437

页数：12

共 84 条

[1] Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study [J].

Abramson, Jeremy S. ;

Solomon, Scott R. ;

Arnason, Jon ;

Johnston, Patrick B. ;

Glass, Bertram ;

Bachanova, Veronika ;

Ibrahimi, Sami ;

Mielke, Stephan ;

Mutsaers, Pim ;

Hernandez-Ilizaliturri, Francisco ;

Izutsu, Koji ;

Morschhauser, Franck ;

Lunning, Matthew ;

Crotta, Alessandro ;

Montheard, Sandrine ;

Previtali, Alessandro ;

Ogasawara, Ken ;

Kamdar, Manali .

BLOOD, 2023, 141 (14) :1675-1684

[2] The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms [J].

Alaggio, Rita ;

Amador, Catalina ;

Anagnostopoulos, Ioannis ;

Attygalle, Ayoma D. ;

Araujo, Iguaracyra Barreto de Oliveira ;

Berti, Emilio ;

Bhagat, Govind ;

Borges, Anita Maria ;

Boyer, Daniel ;

Calaminici, Mariarita ;

Chadburn, Amy ;

Chan, John K. C. ;

Cheuk, Wah ;

Chng, Wee-Joo ;

Choi, John K. ;

Chuang, Shih-Sung ;

Coupland, Sarah E. ;

Czader, Magdalena ;

Dave, Sandeep S. ;

de Jong, Daphne ;

Du, Ming-Qing ;

Elenitoba-Johnson, Kojo S. ;

Ferry, Judith ;

Geyer, Julia ;

Gratzinger, Dita ;

Guitart, Joan ;

Gujral, Sumeet ;

Harris, Marian ;

Harrison, Christine J. ;

Hartmann, Sylvia ;

Hochhaus, Andreas ;

Jansen, Patty M. ;

Karube, Kennosuke ;

Kempf, Werner ;

Khoury, Joseph ;

Kimura, Hiroshi ;

Klapper, Wolfram ;

Kovach, Alexandra E. ;

Kumar, Shaji ;

Lazar, Alexander J. ;

Lazzi, Stefano ;

Leoncini, Lorenzo ;

Leung, Nelson ;

Leventaki, Vasiliki ;

Li, Xiao-Qiu ;

Lim, Megan S. ;

Liu, Wei-Ping ;

Louissaint, Abner, Jr. ;

Marcogliese, Andrea ;

Medeiros, L. Jeffrey .

LEUKEMIA, 2022, 36 (07) :1720-1748

[3] Can we use epigenetics to prime chemoresistant lymphomas? [J].

Amengual, Jennifer E. .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) :85-94

[4] Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients [J].

Bishnoi, Rohit ;

Bajwa, Ravneet ;

Franke, Aaron J. ;

Skelton, William Paul ;

Wang, Yu ;

Patel, Niraj M. ;

Slayton, William Birdsall ;

Zou, Fei ;

Dang, Nam H. .

EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6

[5] How I treat T-cell chronic active Epstein-Barr virus disease [J].

Bollard, Catherine M. ;

Cohen, Jeffrey I. .

BLOOD, 2018, 131 (26) :2899-2905

[6] Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic Score [J].

Caillard, Sophie ;

Porcher, Raphael ;

Provot, Francois ;

Dantal, Jacques ;

Choquet, Sylvain ;

Durrbach, Antoine ;

Morelon, Emmanuel ;

Moal, Valerie ;

Janbon, Benedicte ;

Alamartine, Eric ;

Noble, Claire Pouteil ;

Morel, Delphine ;

Kamar, Nassim ;

Buchler, Matthias ;

Mamzer, Marie France ;

Peraldi, Marie Noelle ;

Hiesse, Christian ;

Renoult, Edith ;

Toupance, Olivier ;

Rerolle, Jean Philippe ;

Delmas, Sylvie ;

Lang, Philippe ;

Lebranchu, Yvon ;

Heng, Anne Elisabeth ;

Rebibou, Jean Michel ;

Mousson, Christiane ;

Glotz, Denis ;

Rivalan, Joseph ;

Thierry, Antoine ;

Etienne, Isabelle ;

Moal, Marie Christine ;

Albano, Laetitia ;

Subra, Jean Francois ;

Ouali, Nacera ;

Westeel, Pierre Francois ;

Delahousse, Michel ;

Genin, Robert ;

de Ligny, Bruno Hurault ;

Moulin, Bruno .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) :1302-1309

[7] The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee [J].

Campo, Elias ;

Jaffe, Elaine S. ;

Cook, James R. ;

Quintanilla-Martinez, Leticia ;

Swerdlow, Steven H. ;

Anderson, Kenneth C. ;

Brousset, Pierre ;

Cerroni, Lorenzo ;

de Leval, Laurence ;

Dirnhofer, Stefan ;

Dogan, Ahmet ;

Feldman, Andrew L. ;

Fend, Falko ;

Friedberg, Jonathan W. ;

Gaulard, Philippe ;

Ghia, Paolo ;

Horwitz, Steven M. ;

King, Rebecca L. ;

Salles, Gilles ;

San-Miguel, Jesus ;

Seymour, John F. ;

Treon, Steven P. ;

Vose, Julie M. ;

Zucca, Emanuele ;

Advani, Ranjana ;

Ansell, Stephen ;

Au, Wing-Yan ;

Barrionuevo, Carlos ;

Bergsagel, Leif ;

Chan, Wing C. ;

Cohen, Jeffrey I. ;

d'Amore, Francesco ;

Davies, Andrew ;

Falini, Brunangelo ;

Ghobrial, Irene M. ;

Goodlad, John R. ;

Gribben, John G. ;

Hsi, Eric D. ;

Kahl, Brad S. ;

Kim, Won-Seog ;

Kumar, Shaji ;

LaCasce, Ann S. ;

Laurent, Camille ;

Lenz, Georg ;

Leonard, John P. ;

Link, Michael P. ;

Lopez-Guillermo, Armando ;

Mateos, Maria Victoria ;

Macintyre, Elizabeth ;

Melnick, Ari M. .

BLOOD, 2022, 140 (11) :1229-1253

[8] Risk-Stratified Sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-Novo Post-Transplant Lymphoproliferative Disorder: Results of the Tidal Trial [J].

Chaganti, Sridhar ;

Maycock, Shanna ;

McIlroy, Graham ;

Iqbal, Waleed A. ;

Mason, John ;

Kanfer, Edward ;

Kassam, Shireen ;

Cwynarski, Kate ;

Wrench, David ;

Arumainathan, Arvind K. ;

Fox, Christopher P. ;

Johnson, Rod ;

McKay, Pam ;

Paneesha, Shankara ;

Rowntree, Clare J. ;

Balotis, Constantine-George ;

Collins, Graham P. ;

Davies, Andrew ;

Wright, Josh ;

Wheatley, Keith ;

Menne, Tobias F. .

BLOOD, 2021, 138

[9] Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children [J].

Chiou, Fang Kuan ;

Beath, Sue V. ;

Wilkie, Gwen M. ;

Vickers, Mark A. ;

Morland, Bruce ;

Gupte, Girish L. .

PEDIATRIC TRANSPLANTATION, 2018, 22 (02)

[10] Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation [J].

Comoli, P. ;

Basso, S. ;

Zecca, M. ;

Pagliara, D. ;

Baldanti, F. ;

Bernardo, M. E. ;

Barberi, W. ;

Moretta, A. ;

Labirio, M. ;

Paulli, M. ;

Furione, M. ;

Maccario, R. ;

Locatelli, F. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (06) :1648-1655

← 1 2 3 4 5 6 7 8 9 →